• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Femtech Startup Rosy Wellness Secures $2M for Women’s Sexual Health

by Jasmine Pennic 11/16/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Femtech Startup Rosy Wellness Secures $2M for Women's Sexual Health

What You Should Know: 

– Femtech startup Rosy Wellness, the app changing the sex lives of women across the country, announced today it raised an additional $2 million in seed funding led by Austin-based True Wealth Ventures with additional participation from Portfolia’s Femtech II Fund and Mindshift Capital. The company will use the funding to support further development of its flagship platform, grow the team, and facilitate original research in women’s sexual health. 

– Founder and CEO, Board-certified Ob/Gyn, Dr. Lyndsey Harper, M.D., FACOG, IF, started Rosy after recognizing that 43% of women had a sexual health problem but were met with a complete lack of resources when trying to solve these important issues. In 2019, Dr. Harper launched Rosy with the goal of putting sexual health education and tools in the hands of women everywhere. 

Recent Research

Recent studies validate Rosy’s approach and highlight how the company stands apart from other platforms in the space. In a 2020 study, results showed that Rosy users experienced statistically significant improvements in many aspects of sexual function including desire, arousal, orgasm, and lubrication. More recently, in a study from Mount Sinai Hospital presented at the American Urogynecology Society Annual Meeting, Dr. Alexandra Dubinskaya et al. concluded that “only one App was approved to be recommended to patients by experts in the field,” and that app was Rosy. This has been echoed in the medical community with more than 6% of ob/gyns in the country now recommending Rosy to their patients

“It’s time women feel empowered to talk about sexual health issues and have access to convenient solutions,” said Dr. Harper. “I created Rosy to revolutionize the way women and their providers think about, talk about, and treat women’s sexual problems.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |